美凱龍(601828.SH)籌劃股權激勵計劃 擬授予權益總計不超3550萬份
格隆匯11月18日丨美凱龍(601828.SH)公佈,公司為進一步完善法人治理結構,建立員工、公司、股東風險共擔、利益共享機制,吸引和保留優秀管理人才和業務骨幹,有效調動管理和業務骨幹的積極性,促進公司長期、持續、健康發展,公司依據《中華人民共和國公司法》、《中華人民共和國證券法》、《上市公司股權激勵管理辦法》等有關法律、法規及規範性文件的規定,擬製定股權激勵計劃。
此次激勵計劃擬授予激勵對象權益總計不超過3550萬份,涉及的標的股票種類為人民幣A股普通股,約佔目前公司股本總額的1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.